Navigation Links
Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ
Date:4/9/2013

Sunnyvale, CA. (PRWEB) April 09, 2013

The sixth session of the Silicon Valley BioTalks tackles the debate “Is EDC becoming a commodity?” The event takes place on April 17 at Onyx Pharmaceuticals headquarters in South San Francisco from 5.30pm – 8.00pm PDT and includes expert panelists from Onyx Pharmaceuticals, Clinical Leader, Clinovo and MedStars. The panel discussion will be simultaneously streamed online.

Described as “a truly informative panel discussion” and “a great forum to hear very experienced clinical trial professionals,” the Silicon Valley BioTalks is the venue for clinical trial professionals looking to stay ahead of trends and technologies in the life science industry. Over 60 healthcare industry professionals attended the most recent sessions, on CDISC standards, systems integration, and FDA regulations.

Wednesday, April 17 - 5.30pm – 8.00pm PDT

The event is free of charge with registration before April 12, 2013: clinovo.com/biotalks

Hosted at Onyx Pharmaceuticals.

The panel is composed of EDC experts Eric Morrie, Manager of Clinical Programming at Onyx Pharmaceuticals, Dr. Omar Dawood of Clinical Leader, Marc Desgrousilliers, CTO at Clinovo and Dr. Bob Molinari, CEO of Retrotype & Partner at MedStars. They will share insights on the evolution of the EDC market over the last 10 years, key players and influencers in the field, best practices for a successful implementation, and how EDC is evolving in today’s marketplace.

With clinical research one of the most expensive areas of drug development, Electronic Data Capture (EDC) has become an increasingly popular solution to lowering costs. Studies suggest that using EDC systems drastically reduces data errors and speeds up the overall trial process, reducing clinical research costs by up to 20%.
Despite the benefits, adoption of EDC systems has remained slow. By December 2012, only 40% of Phase I clinical trials utilized EDC. How can these low adoption rates be explained? Do the currently-available EDC systems effectively meet sponsor companies’ needs?

Event details:
Wednesday, April 17, 2013
5.30pm – 8.00pm PDT

Onyx Pharmaceuticals
249 East Grand Avenue
South San Francisco, California 94080

Register for free before April 12, 2013: clinovo.com/biotalks

Click here to read panelists' bios

  •     Eric Morrie, Manager, Clinical Programming at Onyx Pharmaceuticals
  •     Dr. Omar Dawood, M.D., M.P.H., Visionary Senior Executive and Clinical Leader
  •     Marc Desgrousilliers, Chief Technology Officer at Clinovo
  •     Moderated by Dr. Bob Molinari, Ph.D., C.E.O. at Retrotope & Partner at MedStars

About the Silicon Valley BioTalks
The Silicon Valley BioTalks is a quarterly series of free panel discussions, sponsored by Clinovo, for life science professionals looking to streamline their clinical trials. Representatives from leading pharmaceutical, biotechnology, and medical device companies share expertise and best practices about hot topics in the industry.
Read about the latest sessions on clinovo.com/biotalks

Read the full story at http://www.prweb.com/releases/2013/4/prweb10613870.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Galectin Therapeutics: Turning Atlanta into Americas Next Silicon Valley
2. Building quantum states with individual silicon atoms
3. New material interface improves functioning of non-silicon-based electronic devices
4. New world record efficiency for thin film silicon solar cells
5. Bluestar Silicones Presents Soft Silicone Advantages At Medical Design And Manufacturing (MD&M) West Show
6. Rigaku Publishes Application Note for Accurate Quantitative Analysis of Ferrosilicon by the Fusion Method Using ZSX Primus III+
7. Tiny compound semiconductor transistor could challenge silicons dominance
8. Flexible silicon solar-cell fabrics may soon become possible
9. Fabrication on patterned silicon carbide produces bandgap to advance graphene electronics
10. Rice team boosts silicon-based batteries
11. Aviir Diagnostic Laboratories Secures $8 Million In Funding From Silicon Valley Bank
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. ... today announced the company has entered a license agreement with Roswell Park Comprehensive ... globally exclusive rights to Roswell Park intellectual property surrounding a novel medical device ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the ... today that Derek Fournier has been appointed CEO and President. Founder and former ... immediately. , “DeCurtis Corporation has been on an incredible journey for the ...
(Date:6/23/2020)... ... June 23, 2020 , ... Nobilis Therapeutics, ... that it has filed an Investigational New Drug application (IND) with the U.S. ... its lead drug candidate NBTX-001 in patients with panic disorder (PD). , "Adding ...
(Date:6/11/2020)... , ... June 09, 2020 , ... ... Phase I of a Small Business Innovation Research (SBIR) program funded by the ... Century: Rapid Toxin Detection in the Field”. The project’s goal was to engineer ...
Breaking Biology Technology:
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, a global leader ... Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture of Japan. ... in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible clinical supply ...
(Date:6/28/2020)... ... 2020 , ... In an upcoming episode scheduled for the fall of 2020, ... solutions (POCT). Check local listings for more info. , Today, the majority of testing ... to labs throughout the country. Results are then available several days later. Now, in ...
(Date:6/23/2020)... KEYNES, England (PRWEB) , ... June 23, 2020 ... ... in Africa supporting sustainable healthcare, and Renovagen Ltd, a UK supplier and manufacturer ... response project to support testing operations in the fight against the COVID-19 pandemic ...
Breaking Biology News(10 mins):